Alerts will be sent to your verified email
Verify Email
SUDEEPPHRM
|
Sudeep Pharma
|
Blue Jet Healthcare
|
Anlon Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
2.06 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
30.67 % | 36.48 % | 35.86 % |
|
5yr average Equity Multiplier
|
1.75 | 1.66 | 19.54 |
|
5yr Average Asset Turnover Ratio
|
0.92 | 0.8 | 0.72 |
|
5yr Avg Net Profit Margin
|
20.26 % | 25.9 % | 9.13 % |
|
Price to Book
|
17.72 | 7.98 | 4.19 |
|
P/E
|
63.01 | 28.43 | 43.74 |
|
5yr Avg Cash Conversion Cycle
|
57.48 Days | 115.82 Days | 215.12 Days |
|
Inventory Days
|
44.61 Days | 61.76 Days | 146.25 Days |
|
Days Receivable
|
119.94 Days | 93.28 Days | 172.55 Days |
|
Days Payable
|
85.02 Days | 73.27 Days | 138.78 Days |
|
5yr Average Interest Coverage Ratio
|
33.52 | 1147.29 | 3.68 |
|
5yr Avg ROCE
|
37.68 % | 45.94 % | 16.7 % |
|
5yr Avg Operating Profit Margin
|
27.79 % | 36.06 % | 17.87 % |
|
5 yr average Debt to Equity
|
0.33 | 0.11 | 13.59 |
|
5yr CAGR Net Profit
|
32.99 % | 16.07 % | n/a |
|
5yr Average Return on Assets
|
18.08 % | 20.92 % | 5.99 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
76.15 % | 79.81 % | 52.68 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-23.85 % | -6.19 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.44 % | -0.43 % | 0.0 |
|
Sudeep Pharma
|
Blue Jet Healthcare
|
Anlon Healthcare
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
-
|